|
1
|
Karouzakis E, Neidhart M, Gay RE and Gay
S: Molecular and cellular basis of rheumatoid joint destruction.
Immunol Lett. 106:8–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Müller-Ladner U, Pap T, Gay RE, Neidhart M
and Gay S: Mechanisms of disease: The molecular and cellular basis
of joint destruction in rheumatoid arthritis. Nat Clin Pract
Rheumatol. 1:102–110. 2005. View Article : Google Scholar
|
|
3
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: Key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gravallese EM: Bone destruction in
arthritis. Ann Rheum Dis. 61(Suppl 2): ii84–ii86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Looney RJ: B cell-targeted therapy for
rheumatoid arthritis: An update on the evidence. Drugs. 66:625–639.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma Y and Pope RM: The role of macrophages
in rheumatoid arthritis. Curr Pharm Des. 11:569–580. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Skapenko A, Leipe J, Lipsky PE and
Schulze-Koops H: The role of the T cell in autoimmune inflammation.
Arthritis Res Ther. 7(Suppl 2): S4–S14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yasuda T: Cartilage destruction by matrix
degradation products. Mod Rheumatol. 16:197–205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klareskog L, Catrina AI and Paget S:
Rheumatoid arthritis. Lancet. 373:659–672. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huber LC, Distler O, Tarner I, Gay RE, Gay
S and Pap T: Synovial fibroblasts: Key players in rheumatoid
arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar
|
|
11
|
Lefèvre S, Knedla A, Tennie C, Kampmann A,
Wunrau C, Dinser R, Korb A, Schnäker EM, Tarner IH, Robbins PD, et
al: Synovial fibroblasts spread rheumatoid arthritis to unaffected
joints. Nat Med. 15:1414–1420. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tolboom TC, van der Helm-Van Mil AH,
Nelissen RG, Breedveld FC, Toes RE and Huizinga TW: Invasiveness of
fibroblast-like synoviocytes is an individual patient
characteristic associated with the rate of joint destruction in
patients with rheumatoid arthritis. Arthritis Rheum. 52:1999–2002.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karouzakis E, Gay RE, Gay S and Neidhart
M: Epigenetic control in rheumatoid arthritis synovial fibroblasts.
Nat Rev Rheumatol. 5:266–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tolboom TC, Pieterman E, van der Laan WH,
Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC and Huizinga TW:
Invasive properties of fibroblast-like synoviocytes: Correlation
with growth characteristics and expression of MMP-1, MMP-3, and
MMP-10. Ann Rheum Dis. 61:975–980. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marx RE: Platelet-rich plasma (PRP): What
is PRP and what is not PRP? Implant Dent. 10:225–228. 2001.
View Article : Google Scholar
|
|
16
|
Wang F, Wang NS, Yan CG, Li JH and Tang
LQ: The significance of platelet activation in rheumatoid
arthritis. Clin Rheumatol. 26:768–771. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Endresen GK: Evidence for activation of
platelets in the synovial fluid from patients with rheumatoid
arthritis. Rheumatol Int. 9:19–24. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boilard E, Nigrovic PA, Larabee K, Watts
GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E,
Farndale RW, Ware J and Lee DM: Platelets amplify inflammation in
arthritis via collagen dependent microparticle production. Science.
327:580–583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han J, Meng HX, Tang JM, Li SL, Tang Y and
Chen ZB: The effect of different platelet-rich plasma concentration
on proliferation and differentiation of human periodontal ligament
cells in vitro. Cell Prolif. 40:241–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anitua E, Andia I, Ardanza B, Nurden P and
Nurden AT: Autologous platelets as a source of proteins for healing
and tissue regeneration. Thromb Haemost. 91:4–15. 2004.
|
|
21
|
Kanno T, Takahashi T, Tsujisawa T,
Ariyoshi W and Nishihara T: Platelet-rich plasma enhances human
osteoblast-like cell proliferation and differentiation. J Oral
Maxillofac Surg. 63:362–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Shin MK, Lee JW, Kim YI, Kim YO, Seok H
and Kim NI: The effects of platelet-rich clot releasate on the
expression of MMP-1 and type I collagen in human adult dermal
fibroblasts: PRP is a stronger MMP-1 stimulator. Mol Biol Rep.
41:3–8. 2014. View Article : Google Scholar
|
|
24
|
Kakudo N, Morimoto N, Kushida S, Ogawa T
and Kusumoto K: Platelet-rich releasate promotes angiogenesis in
vitro and in vivo. Med Mol Morphol. 47:83–89. 2014. View Article : Google Scholar
|
|
25
|
Kakudo N, Minakata T, Mitsui T, Kushida S,
Notodihardjo FZ and Kusumoto K: Proliferation-promoting effect of
platelet-rich plasma on human adipose-derived stem cells and human
dermal fibroblasts. Plast Reconstr Surg. 122:1352–1360. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kakudo N, Kushida S, Minakata T, Suzuki K
and Kusumoto K: Platelet-rich plasma promotes epithelialization and
angiogenesis in a split thickness skin graft donor site. Med Mol
Morphol. 44:233–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Volin MV, Huynh N, Klosowska K, Chong KK
and Woods JM: Fractalkine is a novel chemoattractant for rheumatoid
arthritis fibroblast-like synoviocyte signaling through MAP kinases
and Akt. Arthritis Rheum. 56:2512–2522. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gravallese EM, Manning C, Tsay A, Naito A,
Pan C, Amento E and Goldring SR: Synovial tissue in rheumatoid
arthritis is a source of osteoclast differentiation factor.
Arthritis Rheum. 43:250–258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Akakura S and Gelman IH: Pivotal role of
AKAP12 in the regulation of cellular adhesion dynamics: Control of
cytoskeletal architecture, cell migration, and mitogenic signaling.
J Signal Transduct. 2012:5291792012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Murray GI, Duncan ME, O'Neil P, Melvin WT
and Fothergill JE: Matrix metalloproteinase-1 is associated with
poor prognosis in colorectal cancer. Nat Med. 2:461–462. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McGowan PM and Duffy MJ: Matrix
metalloproteinase expression and outcome in patients with breast
cancer: Analysis of a published database. Ann Oncol. 19:1566–1572.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu X, Wang Q, Hu G, Van Poznak C, Fleisher
M, Reiss M, Massagué J and Kang Y: ADAMTS1 and MMP1 proteolytically
engage EGF-like ligands in an osteolytic signaling cascade for bone
metastasis. Genes Dev. 23:1882–1894. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pei D: Matrix metalloproteinases target
protease-activated receptors on the tumor cell surface. Cancer
Cell. 7:207–208. 2005. View Article : Google Scholar : PubMed/NCBI
|
